Navigation Links
Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
Date:6/1/2011

SAN DIEGO, June 1, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) today announced issuance of the U.S. patent covering setrobuvir (ANA598), the Company's Direct-Acting Antiviral (DAA) in Phase IIb development for chronic hepatitis C virus infection (HCV).  U.S. Patent No. 7,939,524, granted to Anadys by the United States Patent and Trademark Office, recognizes the Company's intellectual property rights to the composition of matter and methods of use for setrobuvir (ANA598) and related compounds.  

"Securing U.S. patent protection is a critical step that significantly enhances the value of setrobuvir," said Steve Worland, Ph.D., President and CEO of Anadys.  "This milestone comes at an important juncture in the setrobuvir development program, as we complete enrollment of our Phase IIb trial and begin the investigation of setrobuvir in combination with other DAAs."

About Setrobuvir (ANA598)

Setrobuvir (ANA598), the Company's wholly-owned DAA, is currently in Phase IIb testing in combination with pegylated interferon and ribavirin for the treatment of HCV.  Anadys recently announced a cross-company clinical trial agreement with a large, commercial-stage biopharmaceutical company to study setrobuvir (ANA598) in combination with another DAA in healthy volunteers.  Setrobuvir is the name recently adopted for ANA598 by the United States Adopted Names (USAN) Council.

Setrobuvir (ANA598) is an HCV RNA polymerase inhibitor that belongs to a chemical class referred to as non-nucleosides.  Setrobuvir has a well-characterized safety database in which more than 150 subjects have received the agent to date.  Setrobuvir (ANA598) has received Fast Track Status from the FDA for the treatment of chronic hepatitis C.

About the Phase IIb Study of Setrobuvir (ANA598)

In the ongoing Phase IIb study
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
2. Anadys Pharmaceuticals Appoints Barry Labinger to Its Board of Directors
3. Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
5. Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
6. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
8. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
9. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
10. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013  The American Society ... comprehensive report on the effectiveness of medications for ... these FDA-approved drugs by many state governments and ... than drunk driving car crashes, an epidemic led ... of heroin. Yet, safe and effective medications to ...
(Date:6/17/2013)... 17, 2013 ... Guidebook: Latest Chinese Regulations for Imported ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) ... a fourth population in the world ... drug markets round the world. By ...
(Date:6/17/2013)... SYDNEY , June 17, 2013 ... HTWR ; ASX: HIN), a leading innovator of ... revolutionizing the treatment of advanced heart failure, today ... (FDA) has granted conditional approval to an IDE ... commence enrollment in an additional patient cohort for ...
Breaking Medicine Technology:Effective Rx thwarted for deadly opiate epidemic 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 3China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 4HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 2HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 4
... Fla., Nov. 12 Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) ... months ended September 30, 2009. , Third ... September 30, 2009, the Company reported a net loss of ... a net loss of $2,855,360, or $0.22 per basic and ...
... November 12 According to a new,market research report, ... MarketsandMarkets,( http://www.marketsandmarkets.com ), the global services outsourcing market in,medical ... 2014, growing at a,CAGR of 13.9% from 2009 to ... on Service Outsourcing Opportunities in Medical,Device Market (2009-2014). Early ...
Cached Medicine Technology:Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014 2Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014 3
(Date:6/17/2013)... Tempe, AZ (PRWEB) June 17, 2013 Bust’DD ... are both stylish and well-fitting to women with large busts, ... is founded by two women who understand the problem of ... to other busty women. Their goal is to raise at ... end goal of offering their bras on a wide scale. ...
(Date:6/17/2013)... CA (PRWEB) June 17, 2013 The ... announce a new series of reports highlighting how sustainable ... challenge of growing populations and their demand on food ... an independently produced television series airing in markets around ... by the legendary Martin Sheen, who is marking the ...
(Date:6/17/2013)... 17, 2013 As da Vinci robot ... the country, Bernstein Liebhard LLP notes that a recent report ... some of the disturbing robotic surgery complications alleged to have ... other things, the June 14th broadcast revealed that the U.S. ... reports of da Vinci patients who suffered burns, cuts and ...
(Date:6/17/2013)... City Beach, FL (PRWEB) June 17, 2013 ... higher purpose--fighting hunger. Oceana Naturals LLC, the US distributor ... region of The Bay Area Food Bank ... families, and struggling seniors by seeing that they receive ... Natural Sunscreen and All Natural Moisturizer. Contributions will ...
(Date:6/17/2013)... TX (PRWEB) June 17, 2013 ... to announce that they are now open in ... communities neurofeedback treatments, counseling and access to educational ... that can be used to help with athletic ... Director of the center, Cheryl Camarillo, LCSW, works ...
Breaking Medicine News(10 mins):Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3Health News:All Natural Sunscreen Fights Hunger 2Health News:Professional Center for Enhanced Performance Opens in Schertz 2
... Brain State,Technologies(TM), ( http://www.brainstatetech.com ) along with its,participating ... soldiers from Iraq and Afghanistan. The VA ... in the last year.,According to the VA, more ... from Mental Health disorders, and more than 16,000 ...
... AMERIGROUP,Corporation (NYSE: AGP ) today announced that ... the sale of its assets,including TLC Family Care Health ... approval by the State of Tennessee. The,transaction is expected ... TLC Family Care Health Plan serves about 167,000 low-income ...
... letter sent today,the Foundation for Taxpayer and Consumer Rights ... answer seven questions about,the details of their reported compromise ... even though there are only a few days remaining,in ... FTCR wrote: "Nearly all Californians embrace reform and ...
... Acquisition Corp.,(OTC Bulletin Board: PMQC, PMQCU, PMQCW), a ... has expanded into the Albany, New,York market by ... care,pharmacy from an affiliate of Eden Park Health ... consummated on August 27, 2007, Chem Rx,assumed the ...
... ("Concentra" or the,"Company"), a national leader in on-site ... of medical services and general wellness programs.,Horizon Air, ... known for its,safe, reliable air transportation with caring, ... for an on-site health program that,matched its commitment ...
... Sept. 5 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: ... and Drug,Administration (FDA) has granted final approval for ... Tablets, 3.125 mg,6.25 mg, 12.5 mg and 25 ... agent indicated for the,treatment of left ventricular dysfunction ...
Cached Medicine News:Health News:AMERIGROUP to Acquire Memphis Health Plan 2Health News:AMERIGROUP to Acquire Memphis Health Plan 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 2Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 4Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 5Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 6Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 2Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 3Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 4Health News:Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market 5Health News:Concentra Expands Horizon Air Employee Health Program With On-Site Clinic 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R) 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: